Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings
by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot
Updated on: March 30,2024
0

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings
by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot
Updated on:March 30,2024
0
